Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

43.15
Delayed Data
As of 4:18pm ET
 -2.47 / -5.41%
Today’s Change
42.79
Today|||52-Week Range
55.51
-20.20%
Year-to-Date

Today’s Trading

Previous close45.62
Today’s open45.69
Day’s range42.79 - 45.99
Volume1,320,939
Average volume (3 months)4,933,752
Market cap$24.4B
Dividend yield--
Data as of 4:18pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+15.81%
Earnings growth (next 5 years)+11.27%
Revenue growth (last year)+21.91%
P/E ratio18.6
Price/Sales2.84
Price/Book2.29

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-4.28-4.24%
ZTSZoetis Inc-0.62-1.21%
ALXNAlexion Pharmaceutic...-5.30-3.86%
BMRNBiomarin Pharmaceuti...-4.30-4.32%
Data as of 4:01pm ET, 08/24/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$1.58
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts

Partner Offers

Search for Jobs